BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 29880060)

  • 1. Proteomic analysis of Medulloblastoma reveals functional biology with translational potential.
    Rivero-Hinojosa S; Lau LS; Stampar M; Staal J; Zhang H; Gordish-Dressman H; Northcott PA; Pfister SM; Taylor MD; Brown KJ; Rood BR
    Acta Neuropathol Commun; 2018 Jun; 6(1):48. PubMed ID: 29880060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Proteogenomic Approach to Understanding MYC Function in Metastatic Medulloblastoma Tumors.
    Staal JA; Pei Y; Rood BR
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic profiling of high risk medulloblastoma reveals functional biology.
    Staal JA; Lau LS; Zhang H; Ingram WJ; Hallahan AR; Northcott PA; Pfister SM; Wechsler-Reya RJ; Rusert JM; Taylor MD; Cho YJ; Packer RJ; Brown KJ; Rood BR
    Oncotarget; 2015 Jun; 6(16):14584-95. PubMed ID: 25970789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
    Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
    J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medulloblastoma molecular dissection: the way toward targeted therapy.
    Remke M; Ramaswamy V; Taylor MD
    Curr Opin Oncol; 2013 Nov; 25(6):674-81. PubMed ID: 24076581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic landscape of the childhood cancer medulloblastoma.
    Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
    Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Array-based profiling of reference-independent methylation status (aPRIMES) identifies frequent promoter methylation and consecutive downregulation of ZIC2 in pediatric medulloblastoma.
    Pfister S; Schlaeger C; Mendrzyk F; Wittmann A; Benner A; Kulozik A; Scheurlen W; Radlwimmer B; Lichter P
    Nucleic Acids Res; 2007; 35(7):e51. PubMed ID: 17344319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.
    Hovestadt V; Remke M; Kool M; Pietsch T; Northcott PA; Fischer R; Cavalli FM; Ramaswamy V; Zapatka M; Reifenberger G; Rutkowski S; Schick M; Bewerunge-Hudler M; Korshunov A; Lichter P; Taylor MD; Pfister SM; Jones DT
    Acta Neuropathol; 2013 Jun; 125(6):913-6. PubMed ID: 23670100
    [No Abstract]   [Full Text] [Related]  

  • 10. Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling.
    Forget A; Martignetti L; Puget S; Calzone L; Brabetz S; Picard D; Montagud A; Liva S; Sta A; Dingli F; Arras G; Rivera J; Loew D; Besnard A; Lacombe J; Pagès M; Varlet P; Dufour C; Yu H; Mercier AL; Indersie E; Chivet A; Leboucher S; Sieber L; Beccaria K; Gombert M; Meyer FD; Qin N; Bartl J; Chavez L; Okonechnikov K; Sharma T; Thatikonda V; Bourdeaut F; Pouponnot C; Ramaswamy V; Korshunov A; Borkhardt A; Reifenberger G; Poullet P; Taylor MD; Kool M; Pfister SM; Kawauchi D; Barillot E; Remke M; Ayrault O
    Cancer Cell; 2018 Sep; 34(3):379-395.e7. PubMed ID: 30205043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercellular heterogeneity of expression of the MGMT DNA repair gene in pediatric medulloblastoma.
    Rood BR; Zhang H; Cogen PH
    Neuro Oncol; 2004 Jul; 6(3):200-7. PubMed ID: 15279712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.
    Rivero-Hinojosa S; Grant M; Panigrahi A; Zhang H; Caisova V; Bollard CM; Rood BR
    Nat Commun; 2021 Nov; 12(1):6689. PubMed ID: 34795224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups.
    Bezerra Salomão K; Cruzeiro GAV; Bonfim-Silva R; Geron L; Ramalho F; Pinto Saggioro F; Serafini LN; Antunes Moreno D; de Paula Queiroz RG; Dos Santos Aguiar S; Cardinalli I; Yunes JA; Brandalise SR; Brassesco MS; Scrideli CA; Gonzaga Tone L
    J Neurooncol; 2018 Aug; 139(1):33-42. PubMed ID: 29582271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF1A is Overexpressed in Medulloblastoma and its Inhibition Reduces Proliferation and Increases EPAS1 and ATG16L1 Methylation.
    Cruzeiro GAV; Dos Reis MB; Silveira VS; Lira RCP; Carlotti CG; Neder L; Oliveira RS; Yunes JA; Brandalise SR; Aguiar S; Eterovic AK; Tone LG; Scrideli CA; Valera ET
    Curr Cancer Drug Targets; 2018; 18(3):287-294. PubMed ID: 28302031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-kit expression and mutational analysis in medulloblastoma.
    Chilton-Macneill S; Ho M; Hawkins C; Gassas A; Zielenska M; Baruchel S
    Pediatr Dev Pathol; 2004; 7(5):493-8. PubMed ID: 15547773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hedgehog signaling drives medulloblastoma growth via CDK6.
    Raleigh DR; Choksi PK; Krup AL; Mayer W; Santos N; Reiter JF
    J Clin Invest; 2018 Jan; 128(1):120-124. PubMed ID: 29202464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
    Northcott PA; Shih DJ; Peacock J; Garzia L; Morrissy AS; Zichner T; Stütz AM; Korshunov A; Reimand J; Schumacher SE; Beroukhim R; Ellison DW; Marshall CR; Lionel AC; Mack S; Dubuc A; Yao Y; Ramaswamy V; Luu B; Rolider A; Cavalli FM; Wang X; Remke M; Wu X; Chiu RY; Chu A; Chuah E; Corbett RD; Hoad GR; Jackman SD; Li Y; Lo A; Mungall KL; Nip KM; Qian JQ; Raymond AG; Thiessen NT; Varhol RJ; Birol I; Moore RA; Mungall AJ; Holt R; Kawauchi D; Roussel MF; Kool M; Jones DT; Witt H; Fernandez-L A; Kenney AM; Wechsler-Reya RJ; Dirks P; Aviv T; Grajkowska WA; Perek-Polnik M; Haberler CC; Delattre O; Reynaud SS; Doz FF; Pernet-Fattet SS; Cho BK; Kim SK; Wang KC; Scheurlen W; Eberhart CG; Fèvre-Montange M; Jouvet A; Pollack IF; Fan X; Muraszko KM; Gillespie GY; Di Rocco C; Massimi L; Michiels EM; Kloosterhof NK; French PJ; Kros JM; Olson JM; Ellenbogen RG; Zitterbart K; Kren L; Thompson RC; Cooper MK; Lach B; McLendon RE; Bigner DD; Fontebasso A; Albrecht S; Jabado N; Lindsey JC; Bailey S; Gupta N; Weiss WA; Bognár L; Klekner A; Van Meter TE; Kumabe T; Tominaga T; Elbabaa SK; Leonard JR; Rubin JB; Liau LM; Van Meir EG; Fouladi M; Nakamura H; Cinalli G; Garami M; Hauser P; Saad AG; Iolascon A; Jung S; Carlotti CG; Vibhakar R; Ra YS; Robinson S; Zollo M; Faria CC; Chan JA; Levy ML; Sorensen PH; Meyerson M; Pomeroy SL; Cho YJ; Bader GD; Tabori U; Hawkins CE; Bouffet E; Scherer SW; Rutka JT; Malkin D; Clifford SC; Jones SJ; Korbel JO; Pfister SM; Marra MA; Taylor MD
    Nature; 2012 Aug; 488(7409):49-56. PubMed ID: 22832581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpressed TP73 induces apoptosis in medulloblastoma.
    Castellino RC; De Bortoli M; Lin LL; Skapura DG; Rajan JA; Adesina AM; Perlaky L; Irwin MS; Kim JY
    BMC Cancer; 2007 Jul; 7():127. PubMed ID: 17626635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and proteomic profile of melanotic medulloblastoma.
    Zanini C; Mandili G; Pulerà F; Morra I; Peretta P; Turrini F; Forni M
    Pediatr Blood Cancer; 2009 Jul; 52(7):875-7. PubMed ID: 19061219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastomics: the end of the beginning.
    Northcott PA; Jones DT; Kool M; Robinson GW; Gilbertson RJ; Cho YJ; Pomeroy SL; Korshunov A; Lichter P; Taylor MD; Pfister SM
    Nat Rev Cancer; 2012 Dec; 12(12):818-34. PubMed ID: 23175120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.